Related Experiment Video

Updated: Apr 11, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

19.3K

Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic Tetracycline

Bridget A Quinn1, Rupesh Dash2, Siddik Sarkar1

  • 1Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, Virginia.

Cancer Research
|June 3, 2015
PubMed

Insights

Combining sabutoclax and minocycline shows potent antitumor effects against pancreatic cancer. This novel combination therapy effectively inhibits tumor growth and extends survival in preclinical models.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Pancreatic cancer requires improved treatment strategies.
  • Sabutoclax, a BH3 mimetic, targets antiapoptotic Bcl-2 proteins.
  • Minocycline exhibits antitumor properties.

Purpose of the Study:

  • To evaluate the combinatorial antitumor efficacy of sabutoclax and minocycline in pancreatic cancer.
  • To investigate the underlying mechanisms of this combination therapy.

Main Methods:

  • Preclinical models of pancreatic cancer (immune-deficient and immune-competent).
  • Assessment of cell growth, apoptosis, and cytotoxicity.
  • Analysis of signaling pathways, including phosphorylated Stat3.
  • In vivo tumor growth inhibition and survival studies.

Main Results:

  • Sabutoclax induced pancreatic cancer cell growth arrest and apoptosis.
  • The combination of sabutoclax and minocycline demonstrated synergistic, caspase-dependent cytotoxicity.
  • This synergy was dependent on the loss of phosphorylated Stat3.
  • Combined treatment potently inhibited tumor growth and improved survival in vivo.

Conclusions:

  • The combination of sabutoclax and minocycline is highly cytotoxic to pancreatic cancer cells.
  • This combination therapy is safely efficacious in preclinical models.
  • Targeting Bcl-2 proteins and utilizing minocycline offers a promising therapeutic strategy for pancreatic cancer.

More Related Videos

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

932
Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

28.8K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K